Position in RARE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,469,723
+$2,667,190 QoQ
Shares Held
213,352
+172.2% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 75.69603284712588.ToString("F0")%
Shared 0.ToString("F0")%
None 24.303967152874122.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Man Group plc holds $1,080,100,046 across 125 Biotechnology names. RARE ranks #31 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
315,212 | $243,545,399 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
236,798 | $105,739,778 | |
| 3 | INCY |
Incyte Corp
|
930,171 | $87,547,693 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
232,369 | $76,883,931 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
241,922 | $71,843,576 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
915,689 | $36,838,167 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
275,270 | $26,770,006 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
135,212 | $25,561,828 |
All Filings in RARE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,469,723 | 213,352 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,802,533 | 78,371 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $215,132 | 7,152 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,696,675 | 184,177 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,480,909 | 455,148 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,511,364 | 297,394 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $18,176,125 | 327,203 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $25,840,638 | 628,726 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,173,497 | 153,641 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,199,121 | 87,811 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $831,999 | 23,338 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $1,950,238 | 42,277 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $806,851 | 20,121 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $1,770,314 | 38,211 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,426,077 | 34,438 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,561,660 | 26,176 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $488,296 | 6,724 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $1,895,199 | 16,645 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,249,837 | 45,148 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,678,818 | 32,593 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,235,292 | 28,577 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,659,371 | 37,348 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||